DOCSLIB.ORG

Biocon Limited Unpaid Dividend for the Financial Year Final 2011-12

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biocon Limited Unpaid Dividend for the Financial Year Final 2011-12 Biocon Limited Unpaid Dividend For The Financial year Final 2011-12 SLNO First Name Middle Last Name Address Country State District PINCode Folio Amount Proposed Date of Name Number of Due(in Rs.) transfer to IEPF Securities (DD-MON-YYYY) 1 SURESHKUMARAGARWAL RSONS 58,BAGHDIWAR FATEHPURI DELHI INDIA DELHI NEW DELHI 110006 BIO015133 500.00 30-SEP-2019 2 JAGDISH DAS SHAH HUF CK 19/17 CHOWK VARANASI INDIA UTTAR PRADESH VARANASI BIO040743 500.00 30-SEP-2019 3 RADHESHYAMJUJU 8 A RATAN MAHAL APTS GHOD DOD ROAD SURAT INDIA GUJARAT SURAT 395001 BIO054721 500.00 30-SEP-2019 4 DAMAYANTI BHARAT BHATIA BNP PARIBASIAS OPERATIONS AKRUTI SOFTECH PARK ROAD NO 21 C INDIA MAHARASHTRA MUMBAI 400093 BIO001163 500.00 30-SEP-2019 CROSS ROAD MIDC ANDHERI E MUMBAI 5 JYOTI SINGHANIA CO G.SUBRAHMANYAM, HEAD CAP MAR SER IDBI BANK LTD, ELEMACH INDIA MAHARASHTRA MUMBAI 400093 BIO011395 500.00 30-SEP-2019 BLDG PLOT 82.83 ROAD 7 STREET NO 15 MIDC, ANDHERI EAST, MUMBAI 6 GOKUL MANOJ SEKSARIA IDBI LTD HEAD CAPITAL MARKET SERVIC CPU PLOT NO82/83 ROAD NO 7 INDIA MAHARASHTRA MUMBAI 400093 BIO017966 500.00 30-SEP-2019 STREET NO 15 OPP SPECIALITY RANBAXY LABORATORI ES MIDC ANDHERI (E) MUMBAI-4000093 7 DILIP P SHAH IDBI BANK, C.O. G.SUBRAHMANYAM HEAD CAP MARK SERV PLOT 82/83 INDIA MAHARASHTRA MUMBAI 400093 BIO022473 500.00 30-SEP-2019 ROAD 7 STREET NO 15 MIDC, ANDHERI.EAST, MUMBAI 8 SURAKA IDBI BANK LTD C/O G SUBRAMANYAM HEAD CAPITAL MKT SER C P U PLOT INDIA MAHARASHTRA MUMBAI 400093 BIO043568 500.00 30-SEP-2019 NO 82/83 ROAD NO 7 ST NO 15 OPP RAMBAXY LAB ANDHERI MUMBAI (E) 9 IDBI BANK LTD C/O G SUBRAHMANYAM HEAD CAP MARK SERV CPU PL 30-SEP-2019 82/83 RD 7 ST 15 OPP SPECAILITY RANBAXY LAB MIDC ANDHERI EAST RAMANUJ MISHRA MUMBAI INDIA MAHARASHTRA MUMBAI 400093 BIO047663 500.00 10 30-SEP-2019 C/O KOTAK MAHINDRA BANK LTD VINAYA BHAVYA COMPLEX 5TH FLR 159- URMILA LAXMAN SAWANT A CST ROAD KALINA SANTACRUZ E MUMBAI PHONE- 56768300 INDIA MAHARASHTRA MUMBAI 400098 BIO043838 500.00 11 G SUBRAHMANYAM HEAD CAPITAL MARKET SERVISES CENTRAL 30-SEP-2019 PROCESSING UNIT PLOT NO 82/83 ROAD NO 7 STREET NO 5 MIDC NEHA KAMLESH SHAH ANDHERI (E) MUMBAI INDIA MAHARASHTRA MUMBAI 400093 BIO043408 500.00 12 NO NA INDIA DELHI NEW DELHI BIO054733 250.00 30-SEP-2019 13 NO NA INDIA DELHI NEW DELHI BIO054734 250.00 30-SEP-2019 14 NO NA INDIA DELHI NEW DELHI BIO054748 250.00 30-SEP-2019 15 NO 305 GOLF MANOR WIND TUNNEL ROAD MURUGESHPALYA 30-SEP-2019 MANISH SALNI BANGALORE INDIA KARNATAKA BANGALORE 560017 BIO038066 500.00 16 Madhubani Investments P Ltd G 16 Marina Arcade Connaught Circus New Delhi INDIA DELHI NEW DELHI 110001 IN301774100052678500.00 30-SEP-2019 17 ADITYA MALHOTRA A-3/2 IInd FLOOR JANAKPURI NEW DELHI INDIA DELHI NEW DELHI 110058 IN300394140695263730.00 30-SEP-2019 18 E PRAKASH KURUVILLA 19 NASSIM HILL 06-04 SINGAPORE - 258482 SINGAPORE NA NA IN3001421000502422000.00 30-SEP-2019 19 KULDIP KUMAR SONI W 2B/152 WELLINGTON ESTATE DLF PH V GURGAON INDIA HARYANA ROHTAK 124001 IN3032371021056710000.00 30-SEP-2019 20 Kiran Sidhu Bhatti House, Ravinder Nagar Model Town, JALANDHAR INDIA PUNJAB JALANDHAR 144003 IN300095106330576000.00 30-SEP-2019 21 KAPIL SARAF GOVT GUEST HOUSE CANAL ROAD JAMMU INDIA JAMMU AND KASHMIRJAMMU 180001 IN302349101941842500.00 30-SEP-2019 22 MALATI SINGH 12 D BELI ROAD ALLAHABAD ALLAHABAD INDIA UTTAR PRADESH ALLAHABAD 211002 IN301127158588292500.00 30-SEP-2019 23 ARUN KUMAR SARKAR RAIPUR AGENCIES SINDHI MARKET RAIPUR CG INDIA MADHYA PRADESH RAIPUR 492001 IN301330179487554000.00 30-SEP-2019 24 KAVITHA SONI 16-7-203 DAYAMAMEL COLONY WARANGAL INDIA ANDHRA PRADESH WARANGAL 506002 IN300610107522552500.00 30-SEP-2019 25 NARRA SUBHADRA DEVI 40 9/15 VASAVYA NAGAR PATAMATA VIJAYAWADA INDIA ANDHRA PRADESH VIJAYAWADA 520010 IN302902412885004000.00 30-SEP-2019 26 BGBS WOMENS COLLEGE 7 1 57 GRAND STREET NARSAPUR NARASAPUR 30-SEP-2019 SANTHA CHANGANTI WEST GODAVARI INDIA ANDHRA PRADESH ELURU 534275 IN301774166434962500.00 27 LAKSHMI S N 68/2, 17TH CROSS VEERAPPA BLOCK MALLESWARAM BANGALORE INDIA KARNATAKA BANGALORE 560055 IN302148103358892500.00 30-SEP-2019 28 C ANITA DEVI 6 BADRIYA GARDEN LANE IIND FLOOR CHENNAI CHENNAI INDIA TAMIL NADU CHENNAI 600003 IN301080220283068500.00 30-SEP-2019 29 SAROJA RAO 13/A COLLEGE ROAD 1ST CROSS TIRUPUR INDIA TAMIL NADU COIMBATORE 641602 IN301313206409312700.00 30-SEP-2019 30 KUNHIRAMANPARAYIL 7F S I FLAT GLANDALE POINT BANK ROAD CALICUT INDIA KERALA CALICUT 673001 IN301715320449982500.00 30-SEP-2019 31 30-SEP-2019 PAREED PILLAY T O THARAKANDATHIL THOTTUMUGHOM ALUVA, ERNAKULAM KERALA INDIA KERALA ALWAYE 683105 IN300239102841755000.00 32 IDBI BANK LTD G. SUBRAMANYAM HEAD CA PITAL SERVICES DPU PLOT NO 30-SEP-2019 DEVANANT SEKSARIA 82/83 STREET NO 15 ANDHERI(EAST) MUMABAI INDIA MAHARASHTRA MUMBAI 400093 BIO017737 500.00 33 OM PRAKASH GUPTA 71 DESHPRAN SASMAL ROAD 2ND FLOOR CIT BUILDING KOLKATA INDIA WEST BENGAL KOLKATA 700033 BIO055048 300.00 30-SEP-2019 34 MOINA MERIT PVT LTD 19 R MUKHERJEE ROAD 2ND FLOOR CALCUTTA INDIA WEST BENGAL KOLKATA 700001 BIO950036 10.00 30-SEP-2019 35 VADNAM GANGARAM H NO 1-3-445 INDIRA NAGAR NIRMAL INDIA ANDHRA PRADESH ADILABAD 504106 BIO950079 300.00 30-SEP-2019 36 RISHABH 4 SHIVAJI HSG SOC NR DHARMIK PARIKSHA BOARD 30-SEP-2019 KAMLESH KANWARLAL JAIN AHMEDNAGAR INDIA MAHARASHTRA AHMEDNAGAR 414001 BIO950080 500.00 37 BHARTIBEN DAHYABHAI PATEL 73, DUDHESHWER SOCIETY AJWA ROAD BARODA INDIA GUJARAT BARODA 340019 BIO055030 250.00 30-SEP-2019 38 SURJEET SINGH DESWAL # 719 B SEC 36/B CHANDIGARH INDIA CHANDIGARH CHANDIGARH 160036 BIO950019 1000.00 30-SEP-2019 39 ICI INDIA LTD 5, MALBAR COURT, B G KHER ROAD, MALABAR HILL 30-SEP-2019 ASHOK GANGULY MUMBAI INDIA Maharashtra Mumbai City BIO000151 2500.00 40 KURUVILLA ZACHARIAH THAMARAPALLY HOUSE UNION CLUB ROAD KOTTAYAM INDIA KERALA KOTTAYAM 686001 IN301811101334022500.00 30-SEP-2019 41 RAM JI JAISWAL MERVATIYA OLD BASTI BASTI UP INDIA UTTAR PRADESH BASTI IN301330190860091500.00 30-SEP-2019 42 30-SEP-2019 V T SECURITIES LIMITEDUB-11, ANTRIKSH BHAWAN, 22, K. G. MARG, NEW DELHI NEW DELHI INDIA DELHI NEW DELHI 110001 IN30142810001937 50.00 43 BHAVILA RISHI ANAND A-7 MAYFAIR GARDENS NEW DELHI INDIA DELHI NEW DELHI 110001 IN300644100153481500.00 30-SEP-2019 44 Pansut India Limited 808, Akashdeep Building, 26 A, Barakhamba Road New Delhi INDIA DELHI NEW DELHI 110001 IN300095110425061000.00 30-SEP-2019 45 ANIL BEDI H1 C051 WESTEND HEIGHTS DLF CITY PHASE V GURGAON INDIA HARYANA GURGAON 122009 IN300142101823411000.00 30-SEP-2019 46 NARESH KAPOOR NARESH KAPOOR 576 KATRA NEEL CHANDNI CHOWK DELHI INDIA DELHI NEW DELHI 110006 IN301127155308521000.00 30-SEP-2019 47 ASHOK KUMAR GUPTA 2/92 ROOP NAGAR DELHI INDIA DELHI NEW DELHI 110007 IN301143100614921000.00 30-SEP-2019 48 ANJALI ANAND 6/2 ROOP NAGAR NEW DELHI DELHI INDIA DELHI NEW DELHI 110007 IN30051316173555 90.00 30-SEP-2019 49 MAN MOHAN SHARMA 26/147, WEST PATEL NAGAR NEW DELHI INDIA DELHI NEW DELHI 110008 IN30046810046304250.00 30-SEP-2019 50 RAGHBIR SINGH D- 22 Model Town Delhi INDIA DELHI NEW DELHI 110009 IN30086110107508900.00 30-SEP-2019 51 PUNEET PAL SINGH D 22 MODEL TOWN DELHI INDIA DELHI NEW DELHI 110009 IN30133018530023500.00 30-SEP-2019 52 GURNAM SINGH D 22 MODEL TOWN DELHI INDIA DELHI NEW DELHI 110009 IN301330187617611000.00 30-SEP-2019 53 RAGHBIR SINGH D 22 MODEL TOWN DELHI INDIA DELHI NEW DELHI 110009 IN30133018761779500.00 30-SEP-2019 54 CHANDRIKA KAPOOR 9/205 CARIPPA VIHAR DELHI CANTT NEW DELHI INDIA DELHI NEW DELHI 110010 IN30177412656697 55.00 30-SEP-2019 55 NAND KISHORE SINGH DGEME SECTT ROOM NO 58 B BLOCK NEW DELHI INDIA DELHI NEW DELHI 110011 IN30051313528399 65.00 30-SEP-2019 56 RAMAN MEHTA 1/12 PANT NAGAR JUNGPURA NEW DELHI INDIA DELHI NEW DELHI 110014 IN30105510403624 10.00 30-SEP-2019 57 60/1 BLOCK NO 2 WHS INDUSTRIAL AREA KIRTI NAGAR NEAR DSIDC 30-SEP-2019 VIKRAM SINGLA COMPLEX DELHI DELHI,INDIA INDIA DELHI NEW DELHI 110015 IN30290249681222 60.00 58 KrishnakumarS C/o Virender Kumar 43, SFS Flats Haug Khaz New Delhi INDIA DELHI NEW DELHI 110016 IN30009510068701500.00 30-SEP-2019 59 JASVINDER SINGH CHOUDHARY G 16/7 MALVIYA NAGAR NEW DELHI INDIA DELHI NEW DELHI 110017 IN30256610002068200.00 30-SEP-2019 60 SANTOSH SINGH SALOOJA 104 - F , POCKET K , SHEIKH SARAI , PHASE 2 NEW DELHI INDIA DELHI NEW DELHI 110017 IN30014210172973180.00 30-SEP-2019 61 VINOD MEHTA G14/12 BLOCK G 14 MALVIYA NAGAR DELHI DELHI INDIA DELHI NEW DELHI 110017 IN30051319205233 50.00 30-SEP-2019 62 MEENAKSHI BAZAZ 15C UJJWAL APTS VIKASPURI NEW DELHI INDIA DELHI NEW DELHI 110018 IN30267930249548175.00 30-SEP-2019 63 30-SEP-2019 AJAY KUMAR BHATIA 86-C POCKET A-14, HIMGIRI APARTMENTS KALKAJI EXTN NEW DELHI INDIA DELHI NEW DELHI 110019 IN30323710016942125.00 64 ANINDYA BASU I-1678 CHITTRANJAN PARK NEW DELHI INDIA DELHI NEW DELHI 110019 IN300142102073611000.00 30-SEP-2019 65 MAHESH CHANDRA SHARMA J-1/257, D. D. A. FLATS KALKA JI NEW DELHI INDIA DELHI NEW DELHI 110019 IN30105510216923100.00 30-SEP-2019 66 86 ASHIAN GAMES VILLAGE COMPLEX BHAKTAWAR SINGH BLOCK TYPE-5- 30-SEP-2019 V K GARG A GROUND FLOOR NEW DELHI INDIA DELHI NEW DELHI 110019 IN301055105937551000.00 67 PRAVEEN VERMA 142 MANDAKINI ENCLAVE ALAKNANDA KALKAJI DELHI INDIA DELHI NEW DELHI 110019 IN30177412165207250.00 30-SEP-2019 68 RENU KHANNA F 58 G F KALKAJI DELHI DELHI INDIA DELHI NEW DELHI 110019 IN300214125230521500.00 30-SEP-2019 69 SATYAJIT CHATTERJEE SECTOR- I QUARTER NO.
Load more

Recommended publications
  • Sl No. Reg No. NAME and ADDRESS 1 Reg No.17478 Reg No 9415 Shri Yallappa Dhulikoppa S/O Basavalingappa No
    Sl No. Reg No. NAME AND ADDRESS 1 Reg No.17478 Reg No 9415 Shri Yallappa Dhulikoppa S/o Basavalingappa No. 40, Chikkadasarahalli, Neriga Post, Sarjapur Hobli, Bangalore-562 125 M-98804-88772 2 Reg No.17479 Reg No 9770 Shri Ambareesha D No. 79, Megha Hospet, Bhayasabi Layout, Vivekanand Cross, Anekal, Bangalore-562 106 M-90086-75889 3 Reg No.17480 Reg No.11914 Shri B.R.Nandeesh Aradhya No.68/2, 'Basaveshwara Nilaya' Vidyanagar, 4th Cross, Bommasandra Industrial Area Tq-Anekal, Bangalore-560 099 Mo-99867-18414 E- [email protected] 4 Reg No.19604 Reg No 12890 Shri Muddaveerappa S/o Channapparadhya At-Hilalalige (Gate) Post-Chandapur, Attibele Hobli Tq-Anekal, Bangalore North Mo-9449648129 5 Reg No.24386 Reg No 12930 Shri Purushotham Y.R. S/o H.N.Rudramuniyappa Mahadeshwara Stores, H.N.R. Comples, Yadavanahalli Gate Attibele Hobli, Tq-Anekal Bangalore-562107 Mo- 9916970059 6 Reg No.24388 Reg No 12931 Shri Arun Aradhya M S/o Mallikarjuna At & Post-Yadavanahalli-562 107 Attibele Hobli, Tq-Anekal, Bangalore Mo- 9900776813 7 Reg No.27985 Reg No.13438 Shri Sharanabasava Hiremath S/o H.M.Siddaiah S.M.M.Enterprises, Gopalareddy Building Near Canara Computer, Vinayakanagar, Tirupalya Road, Hebbagodi Bangalore-560 099 Mo- 9880545450 8 Reg No.2360 Reg No.13439 Shri Basavaraja Moke S/o Jambanna Moke Sharma Building, Gollahalli Road, Near S.B.I.(ATM) Hebbagodi Bangalore-560 099 Mo-9945975209 9 Reg No.2361 Reg No.13440 Shri Ravi Chandra E S/o Eshwarappa Susheelamma Building, Vinayakanagar Hebbagodi Bangalore-560 099 Mo-9880610078 10 Reg No.11711 Reg No.13441 Shri Veeresh Lalasangi S/o Shivaputrappa NO.52, Balappa Reddy Building Vinayakanagar Hebbagodi Bangalore-560 099 Mo-9739476464 11 Reg No.11712 Reg No.13442 Smt Dhakshayini L.K.
    [Show full text]
  • Biocon Annual Report 2014
    Annual Report 2014 Tryst and Trust Tryst and Trust Annual Report Biocon Limited 20th KM Hosur Road, Electronic City, Bangalore – 560 100, India T – 91 80 2808 2808 2014 E – corporate.communications@ biocon.com W – www.biocon.com Forward Looking Statement In this Annual Report we have disclosed forward-looking information to enable investors to comprehend our prospects and take informed investment decisions. This report and other statements - written and oral - that we periodically make contain forward-look- ing statements that set out anticipated results based on the management’s plans and assumptions. We have tried wherever possible to identify such statements by using words such as ‘anticipates’, ‘estimates’, ‘expects’, ‘projects’, ‘intends’, ‘plans’, ‘believes’ and words of similar substance in connection with any discussion of future performance. The market data & rankings used in the various chapters are based on several published reports and internal company assessment. We cannot guarantee that these forward looking statements will be realised, although we believe we have been prudent in our assumptions. The achievement of results is subject to risks, uncertainties and even inaccurate assumptions. Should known or unknown risks or uncertainties materialise, or should underlying assumptions prove inaccurate, actual res- ults could vary materially from those anticipated, estimated or projected. Readers should bear this in mind. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new
    [Show full text]
  • To View BMRCL Annual Report 2019-20
    I N D E X 1. Board of Directors ............................................................................................................ 2 2. Notice of AGM ................................................................................................................. 4 3. Chairman’s Speech ........................................................................................................... 6 4. Board’s Report ................................................................................................................. 9 5. Independent Auditor’s Report ....................................................................................... 66 6. Comments of the Comptroller and Auditor General of India......................................... 82 7. Balance Sheet as at 31st March, 2020............................................................................. 84 8. Statement of Profit and Loss for the year ended 31st March, 2020 ............................... 86 9. Cash Flow Statement for the year ended 31st March, 2020 ........................................... 90 10. Notes to the Financial Statements ................................................................................. 92 1 BOARD OF DIRECTORS Shri Durga Shanker Mishra Chairman, BMRCL & Secretary - Ministry of Housing and Urban Affairs, Government of India Shri Ajay Seth Managing Director, BMRCL Shri Jaideep Director, BMRCL &OSD (UT) and Ex-Officio Joint Secretary, Ministry of Housing and Urban Affairs, Government of India Shri K. K. Saberwal Director, BMRCL
    [Show full text]
  • Women Achievers 2011
    Women Achievers i TABLE OF CONTENTS Introduction iii Message v Foreword vi NEELAM DHAWAN 1 PRIYA CHETTY RAJAGOPAL 2 SUCHITRA K ELLA 4 SUDHA IYER 5 ANURADHA SRIRAM 6 AKILA KRISHNAKUMAR 8 KIRAN MAZUMDAR SHAW 9 DEEPTI REDDY 10 REKHA M MENON 11 REVATHI KASTURI 13 SANDHYA VASUDEVAN 15 Dr VILLOO MORAWALA PATEL 16 AMUKTA MAHAPATRA 18 Dr REKHA SHETTY 19 YESHASVINI RAMASWAMY 21 BEENA KANNAN 23 BINDU ANANTH 24 PARVEEN HAFEEZ 25 MALLIKA SRINIVASAN 26 SUSHMA SRIKANDTH 27 SHEELA KOCHOUSEPH 29 HASTHA KRISHNAN 30 HEMALATHA RAJAN 31 HEMA RAVICHANDAR 32 KAMI NARAYAN 34 UMA RATNAM KRISHNAN 35 SHALINI KAPOOR 37 PREETHA REDDY 38 ii Women Achievers Dr. THARA SRINIVASAN 40 AKHILA SRINIVASAN 42 RAJANI SESHADRI 43 SHOMA BAKRE 44 SANGITA JOSHI 45 GAYATHRI SRIRAM 46 JAYSHREE VENKATRAMAN 48 GEETANJALI KIRLOSKAR 49 KALPANA MARGABHANDU 50 SHARADA SRIRAM 51 SAMANTHA REDDY 53 SHOBHANA KAMINENI 54 VINITA BALI 56 RAJSHREE PATHY . 58 GEETHA VISWANATHAN 59 VALLI SUBBIAH 60 RANJINI MANIAN 62 VANITA MOHAN 63 TILISA GUPTA KAUL 64 SHARAN APPARAO 65 SUNEETA REDDY 66 VANAJA ARVIND 67 Dr. KAMALA SELVARAJ 69 SAKUNTALA RAO 70 NEETA REVANKER 71 MAURA CHARI 73 HAMSANANDHI SESHAN 75 MAHIMA DATLA 77 Dr. NIRMALA LAKSHMAN 78 NANDINI RANGASWAMY 79 PRITHA RATNAM 81 Dr. THARA THYAGARAJAN 82 REVATHY ASHOK 83 SANGITA REDDY 85 GEEHTA PANDA 87 Women Achievers iii INTRODUCTION In the last two decades Indian women have entered work force in large numbers and many of them hold senior positions now Gone are the days when we hardly saw women in lead- ership positions in organizations Some of India’s
    [Show full text]
  • Office of the Additional Director General of Foreign Trade, Bengaluru
    OFFICE OF THE ADDITIONAL DIRECTOR GENERAL OF FOREIGN TRADE, BENGALURU EXPORT HOUSE DETAILS FOR THE PERIOD 2015-20 EXPORT HOUSE CERTIFICATES ISSUED IN 2016-17 01 0797003967 HILLTOP STONES PRIVATE LIMITED., 1 Star 2020 A/5911 dtd. NO.1/18,1/19,1/4-1,1/4- 25.04.2016 3,BANNERGHAT TA ROAD,NEAR MICO BACK GATE BANGALORE-560030 02 0788004549 JINDAL ALUMINIUM LTD 2 Star 2020 A/5906 dtd. 16 TH K M TUMKUR ROAD 20.04.2016 BANGALORE -560073 03 0793017289 KARLE INTERNATIONAL PVT LTD 2 Star 2020 B/2860 dtd. NO.151, INDL. SUBURB, 19.05.2016 YESHWANTHPUR, BANGALORE- 560022 04 0789009269 ANGLO-FRENCH DRUGS & 1 Star 2020 A/5916 dtd. INDUSTRIES LTD 19.05.2016 41,3RD CRS.BLOCK V, RAJAJINAGAR, BANGALORE-560010 05 0788000250 STERLING FOODS 2 Star 2020 B/2861 dtd. MILAGRES CENTRE,2ND 01.06.2016 FLR.HAMPANKATTA, MANGALORE- 575001 06 0794012094 SREEDEVI CASHEW INDUSTRIES 2 Star 2020 B/2859 dtd. MUDAR, BAJAGOLI, KARKALA TALUK, 19.05.2016 UDUPI, KARNATAKA-574122 07 0388038047 ABB LIMITED 3 Star 2020 C/1622 dtd. BRIGADE GATEWAY CAMPUS, 26/1, 13.05.2016 DR.RAJKUMAR ROAD, MALLESHWARAM, BANGALORE- 560055 08 0788000560 BIOCON LIMITED, 3 Star 2020 JB/0710 dtd. 20TH K M, HOSUR ROAD, 05.04.2016 ELECTRONIC CITY P.O, BANGALORE -560100 09 0700016031 SKF TECHNOLOGIES INDIA PVT LTD 1 Star 2020 A/5907 dtd. PLOT NO.2 BOMMASANDRA INDL 21.04.2016 AREA,BANGALORE -560099 10 0701004461 KENMORE SHOES PVT LTD 2 Star 2020 B/2857 dtd. GOVINDAPURAM MAIN 19.05.2016 ROAD,NAGAWARA BANGALORE-560045 11 0793003580 ARON UNIVERSAL LTD 1 Star 2020 A/5914 dtd.
    [Show full text]
  • Biocon Biologics Joins Hands with IDF in Its Mission to Promote Diabetes Care, Prevention and Effective Management Worldwide”
    Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com February 16, 2021 To, To, The Manager The Manager BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code – 532523 Scrip Symbol - Biocon Subject: Press Release titled “Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide”. Dear Sir/Madam, Please find enclosed the press release titled “Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide”. The above information will also be available on the website of the Company at www.biocon.com. Kindly take the same on record and acknowledge. Thanking You, Yours faithfully, For Biocon Limited _______________ Mayank Verma Company Secretary and Compliance Officer PRESS RELEASE Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide First Biosimilar Insulin Company to Partner with International Diabetes Federation (IDF) Bengaluru, Karnataka; INDIA: February 16, 2021 Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), is pleased to partner with The International Diabetes Federation (IDF) as the first biosimilar insulin company to promote and support IDF’s Core Mission initiative and activities. This important partnership with IDF coincides with the start of the centenary celebrations of the discovery of insulin and takes forward Biocon Biologics’ mission of enabling affordable access to insulins to people with diabetes worldwide.
    [Show full text]
  • Adagio Therapeutics Partners with Biocon Biologics to Bring Potent
    Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets Waltham, MA – July 26, 2021 – Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced a partnership agreement with Biocon Biologics Ltd., to combat the ongoing COVID-19 crisis in southern Asia. Biocon Biologics Ltd. is a fully integrated biosimilars company and a subsidiary of Biocon Ltd., a global biopharmaceuticals company, (BSE code: 532523, NSE: BIOCON). Under the terms of the agreement, Adagio will provide Biocon with materials and know-how to manufacture and commercialize an antibody treatment based on ADG20 in India and additional select emerging markets. ADG20, Adagio’s lead product candidate, is designed to be a potent, long-acting and broadly neutralizing antibody for both the treatment and prevention of COVID-19 as either a single or combination agent. Unlike other antibody-based therapies specifically targeting SARS-CoV-2, ADG20 has demonstrated an ability to neutralize SARS-CoV-2 in non-clinical studies, including variants of concern, as well as a broad range of other SARS-like viruses. ADG20 is currently being evaluated in two separate Phase 2/3 global clinical trials, the STAMP trial to evaluate ADG20 for the treatment of non-hospitalized COVID-19 patients and the EVADE trial to evaluate ADG20 for the prevention of COVID-19. “This partnership underscores the commitment of two companies to come together in order to make a significant impact on global health,” said Tillman Gerngross, Ph.D., co-founder and chief executive officer of Adagio.
    [Show full text]
  • Biocon Moves up to Rank No. 6 on Science Careers' Top 20 Global Pharma & Biotech Employers List 2019"
    <$Biocon Biocon Limited 20th KM Hosur Road Electronics City Bangalore 560-100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA 1978PLC003417 www.biocon.com October 28, 2019 To To The Manager The Manager, BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Sandra Kurla Complex Dalal Street, Mumbai -400 001 Mumbai- 400 050 Scrip Code - 532523 Scrip Symbol- Biocon Dear Sir/Madam, Subject: Press Release Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed the press release titled "Biocon Moves Up to Rank No. 6 on Science Careers' Top 20 Global Pharma & Biotech Employers list 2019". The above information will also be available on the website of the Company at www.biocon.com. Kindly take the same on record and acknowledge. Thanking You, Yours faithfully, For Biocon Li mited Mayank Verma Company Secretary & Compliance Officer Enclosed: Pre ss Release Press Release Biocon Moves Up to Rank No. 6 on Science Careers’ Top 20 Global Pharma & Biotech Employers List 2019 Bengaluru, Karnataka, India, October 28, 2019 Biocon Ltd, an innovation-led global biopharmaceuticals company, has moved up in the Top 10 Global Biotech Employers ranking for 2019 and continues to be the only Company from Asia to feature on the prestigious U.S.-based Science magazine’s annual ‘Science Careers Top 20 Employers’ list, since its debut in 2012. Ranked at No. 6 among global pharma and biotech companies in 2019, Biocon has moved up from No.
    [Show full text]
  • Proposed Date of Securities Rs.) Transfer to IEPF (DD- MON-YYYY) DILIP P SHAH IDBI BANK, C.O
    Biocon Limited Amount of unclimed and unpaid final dividend for FY 2007-08 First Name Middle Name Last Name Address Country State District PINCode Folio Number of Amount Due(in Proposed Date of Securities Rs.) transfer to IEPF (DD- MON-YYYY) DILIP P SHAH IDBI BANK, C.O. G.SUBRAHMANYAM HEAD INDIA MAHARASHTRA MUMBAI 400093 BIO022473 250.00 22-AUG-2015 CAP MARK SERV PLOT 82/83 ROAD 7 STREET NO 15 MIDC, ANDHERI.EAST, MUMBAI SURAKA IDBI BANK LTD C/O G SUBRAMANYAM HEAD INDIA MAHARASHTRA MUMBAI 400093 BIO043568 250.00 22-AUG-2015 CAPITAL MKT SER C P U PLOT NO 82/83 ROAD NO 7 ST NO 15 OPP RAMBAXY LAB ANDHERI MUMBAI (E) RAMANUJ MISHRA IDBI BANK LTD C/O G SUBRAHMANYAM INDIA MAHARASHTRA MUMBAI 400093 BIO047663 250.00 22-AUG-2015 HEAD CAP MARK SERV CPU PL 82/83 RD 7 ST 15 OPP SPECAILITY RANBAXY LAB MIDC ANDHERI EAST MUMBAI URMILA LAXMAN SAWANT C/O KOTAK MAHINDRA BANK LTD VINAYA INDIA MAHARASHTRA MUMBAI 400098 BIO043838 250.00 22-AUG-2015 BHAVYA COMPLEX 5TH FLR 159-A CST ROAD KALINA SANTACRUZ E MUMBAI PHONE- 56768300 NEHA KAMLESH SHAH G SUBRAHMANYAM HEAD CAPITAL MARKET INDIA MAHARASHTRA MUMBAI 400093 BIO043408 250.00 22-AUG-2015 SERVISES CENTRAL PROCESSING UNIT PLOT NO 82/83 ROAD NO 7 STREET NO 5 MIDC ANDHERI (E) MUMBAI NO NA INDIA DELHI NEW DELHI BIO054733 250.00 22-AUG-2015 NO NA INDIA DELHI NEW DELHI BIO054734 250.00 22-AUG-2015 NO NA INDIA DELHI NEW DELHI BIO054748 250.00 22-AUG-2015 MANISH SALNI NO 305 GOLF MANOR WIND TUNNEL ROAD INDIA KARNATAKA BANGALORE 560017 BIO038066 22-AUG-2015 MURUGESHPALYA BANGALORE 250.00 Madhubani Investments P Ltd G 16 Marina Arcade Connaught Circus New INDIA DELHI NEW DELHI 110001 IN30177410005267 Delhi 4250.00 22-AUG-2015 VANDANA GOGIA HOUSE NO.904 SECTOR-28 FARIDABAD INDIA HARYANA FARIDABAD 121002 IN30209210046456 2500.00 22-AUG-2015 GEETA SINGH C/O JITENDRA PRATAP SINGH RESIDENT INDIA UTTAR PRADESH SULTANPUR 228001 IN30055610009786 ENGINEER TEMPORARY DEPART.
    [Show full text]
  • Biocon Biologics Is Talking to Several Governments for Ways to Disintermediate the Supply of Insulin
    Biocon Limited THE ANNUAL REPORT 2020 Touching a billion lives through MANIFESTO affordable innovation 1 THE IMPACT MANIFESTO ANNUAL REPORT 2020 Biocon Limited Transforming lives through meaningful impact Sharp inequities in access have denied the benefits from advances in medical science to almost a third of the world’s population. Hefty price tags on life-saving drugs have created unbearable financial burden for patients in most of the world. Inadequate research spending has led to a fragile medical innovation ecosystem with serious repercussions on global preparedness for health emergencies. The vulnerability of healthcare systems worldwide to a global pandemic stands exposed. 2 THE IMPACT MANIFESTO ANNUAL REPORT 2020 Biocon Limited Biocon is leveraging its affordable innovation model to reduce disparities in access to safe, high-quality medicines, as well as, address the gaps in scientific research to find innovative solutions to impact a billion lives. Take a quantum leap in serving the needs of our patients through innovative solutions that go beyond the product. Transform patient lives through the introduction of therapies that improve treatment outcomes while enhancing their health and well-being. Dramatically improve patient survival and, if possible, cure hitherto incurable diseases through advanced targeted therapies. Put the care back in healthcare by pursuing a humanitarian path to ensure better patient care and outcomes while reducing costs through our ‘high-quality, low cost, high volume’ business model. ANNUAL REPORT 2020 THE IMPACT MANIFESTO 3 Biocon Limited The Biocon Manifesto We seek to leverage differentiated technologies to transform healthcare by ensuring access to affordable, quality assured, complex therapies that significantly improve patient outcomes and are available to all.
    [Show full text]
  • Market Pulse February2011
    Re. 1/- Profit is the Answer Volume 1 : Issue 11, 8th February 2011 Total Pages: 4 Dear Friends, Global Economy - Nitin Agarwal US: US economy is showing signs of strengthening backed by In India, when the people and industry performs well, somewhere the politicians up there play havoc. Payroll gains which picked up in January’11 even after ac- Today, despite market current being bullish, there is no sight of reforms or no implementation of counting for the restraining influence of winter storms. Employ- ment increased by 146,000 workers last month after a 103,000 promises made by the political administrator. This has put the market into a forceful down trend, gain in December’10. Economic growth accelerated to a 3.2 which shows India and its policy makers in poor light and triggered sale by FII more commentary on % annual rate in the Q4’FY10 as consumer spending climbed the working of political administrators than economy. by the most in more than four years. U.S. GDP advanced at a 3.2 % annual rate in the Q4’FY10. PMI also accelerated in When we factor the market, we only look at the profitability of the Companies, international scenar- January’11 at the fastest pace since May 2004. Companies like Ford Motor Co. and Emerson Electric Co. are hiring as ios, but, obviously nobody can factor that somewhere up there, there will be huge corruption and consumer spending, business investment and exports climb. scams which can result into down trend in the market. The recovery in US economy is also helping boost the confi- dence of real estate investors.
    [Show full text]
  • Biocon Biologics Investor Presentation Transforming Healthcare
    Biocon Biologics Investor Presentation Transforming Healthcare. Transforming Lives June 2020 1 Safe Harbour Certain statements in this release concerning our future growth prospects are forward-looking statements, which are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those contemplated in such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, amongst others general economic and business conditions, our ability to successfully implement our strategy, our research and development efforts, our growth and expansion plans and technological changes, changes in the value of the Rupee and other currencies, changes in the Indian and international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the biotechnology and pharmaceuticals industries, changes in political conditions and changes in the foreign exchange control regulations. Neither the company, nor its directors and any of the affiliates have any obligation to update or otherwise revise any statements reflecting circumstances arising after this date or to reflect the occurrence of underlying events, even if the underlying assumptions do not come to fruition 2 Introduction 3 Biocon Biologics Uniquely positioned as fully integrated player for biosimilars 2 740+ 28 5 Development Partnerships Registered Products Products taken (Mylan, Sandoz) Trademarks* in pipeline from Lab to Market 4000+ ~860 ~120 High Quality, Diverse Patents granted Countries where our Employees (Biologics)* products are available 2 3 25+ 4 R&D sites Manufacturing sites (2 cGMP approvals from Office locations (Bangalore, Chennai) Bangalore, 1 Malaysia) International regulatory agencies** around the globe *Status Jun 2019 **Key regulatory approvals from US, EU, Japan, Canada, Australia, Brazil, Mexico, Turkey, GCC etc.
    [Show full text]